why choose us

First received: September 13, 2022

Clinical Trial: Study to Evaluate the Safety, Tolerability, and PK of Pacritinib

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label, Multiple-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Pacritinib in Subjects With Varying Degrees of Hepatic Impairment Compared to Healthy Subjects

Brief Summary: This is a Phase 1 study designed to assess the effect of hepatic insufficiency on the PK of pacritinib by study of 14-day BID dosing of pacritinib in subjects with moderate and severe hepatic impairment compared to healthy matched control subjects with normal liver function.Safety and tolerability of multiple day dosing of pacritinib in the subject populations will also be evaluated.

Read more